China Nepstar Chain Drugstore Ltd (NPD) 2.45 $NPD China

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
China Nepstar Chain Drugstore Ltd (NPD) 2.45 $NPD

China Nepstar Chain Drugstore Ltd. Reports First Quarter 2016 Financial Results
PR Newswire - Tue May 31, 3:52AM CDT
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company" , a leading retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the first quarter ended March 31, 2016.
NPD: 2.45 (+0.01)

Investor Calendar Invites You to the China Nepstar Chain Drugstore First Quarter 2016 Earnings Conference Call on Tuesday, May 31, 2016
ACCESSWIRE - Fri May 27, 3:10PM CDT
SHENZHEN, CHINA / ACCESSWIRE / May 27, 2016 / China Nepstar Chain Drugstore Ltd. (NYSE: NPD) will host a conference call to discuss the results of the first quarter 2016, to be held Tuesday, May 31, 2016 at 8:00 AM Eastern Time.
NPD: 2.45 (+0.01)

China Nepstar Chain Drugstore to Report First Quarter 2016 Financial Results on May 31, 2016
PR Newswire - Wed May 25, 3:14AM CDT
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company" , a leading retail drugstore chain in China based on the number of directly operated stores, today announced that the Company will report its unaudited financial results for the first quarter of 2016 on May 31, 2016 before the market opens.
NPD: 2.45 (+0.01)

China Nepstar Chain Drugstore Filed 2015 Annual Report on Form 20-F
PR Newswire - Wed Apr 27, 3:00AM CDT
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company" , a leading retail drugstore chain in China based on the number of directly operated stores, today announced the Company filed its annual report on Form 20-F for the year ended December 31, 2015 with the Securities and Exchange Commission on April 26, 2016. The annual report can be accessed on the Company's investor relations website at http://ir.nepstar.cn. The Company will provide a hard copy of the annual report containing its audited financial statements for the year ended December 31, 2015, free of charge, to its shareholders and ADS holders upon request.
NPD: 2.45 (+0.01)

Investor Calendar Invites You to the China Nepstar Chain Drugstore Fourth Quarter and Fiscal Year 2015 Earnings Conference Call on Tuesday, March 29, 2016
ACCESSWIRE - Mon Mar 28, 3:07PM CDT
SHENZHEN, CHINA / ACCESSWIRE / March 28, 2016 / China Nepstar Chain Drugstore Ltd. (NYSE: NPD) will host a conference call to discuss the results of the fourth quarter and fiscal year 2015, to be held Tuesday, March 29, 2016 at 8:00 AM Eastern Time.
NPD: 2.45 (+0.01)

China Nepstar Chain Drugstore Ltd. Enters into Definitive Merger Agreement for Going Private Transaction
PR Newswire - Wed Mar 16, 7:52AM CDT
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company" , a leading retail drugstore chain in China based on the number of directly operated stores, announced today that it has entered into a definitive Agreement and Plan of Merger (the "Merger Agreement" with China Neptunus Drugstore Holding Ltd. ("Parent" and Neptunus Global Limited ("Merger Sub" , a wholly-owned subsidiary of Parent.
NPD: 2.45 (+0.01)

These China Focused Small Cap Stocks Have Interesting Growth Stories
ACCESSWIRE - Tue Nov 17, 7:00AM CST
MIAMI, FL / ACCESSWIRE / November 17, 2015 / China has been one of the most down-beat countries over the last few quarters with equities losing value across board. However, not everything about China is all bad, especially when looking at some of the most promising small cap plays traded in the US.
NPD: 2.45 (+0.01), CJJD: 1.59 (-0.07), LITB: 2.66 (+0.02)

China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2015 Financial Results
PR Newswire - Wed Sep 02, 3:00AM CDT
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company" , a leading retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the second quarter ended June 30, 2015.
NPD: 2.45 (+0.01)

China Nepstar Chain Drugstore to Report Second Quarter 2015 Financial Results on September 2, 2015
PR Newswire - Tue Aug 11, 3:00AM CDT
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company" , a leading retail drugstore chain in China based on the number of directly operated stores, today announced that the Company will report its unaudited financial results for the second quarter of 2015 on September 2, 2015 before the market opens.
NPD: 2.45 (+0.01)

China Nepstar Chain Drugstore Ltd. Special Committee Retains Financial Advisor and Legal Counsel
PR Newswire - Thu Aug 06, 3:43AM CDT
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company" , a leading retail drugstore chain in China based on the number of directly operated stores, today announced that the special committee (the "Special Committee" of the Company's board of directors has retained Houlihan Lokey (China) Limited as its financial advisor and Shearman & Sterling LLP as its United States legal counsel in connection with its review and evaluation of the previously announced preliminary non-binding "going private" proposal letter that the Company's board of directors received on July 6, 2015.
NPD: 2.45 (+0.01)

China Nepstar Chain Drugstore Ltd. Announces Formation of Special Committee to Consider "Going Private" Proposal
PR Newswire - Fri Jul 17, 7:38PM CDT
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company" , a leading retail drugstore chain in China based on the number of directly operated stores, today announced that its board of directors (the "Board" has formed a special committee consisting of three independent directors (the "Special Committee" , Mr. Barry J. Buttifant, Mr. Alistair Eric MacCallum Laband and Mr. Alan Au, to consider the previously announced preliminary non-binding "going private" proposal letter that the Board received on July 6, 2015. Mr. Barry J. Buttifant will chair the Special Committee. The Special Committee intends to retain independent legal and financial advisors to assist it in this process.
NPD: 2.45 (+0.01)

China Stock Roundup: Mindray Medical to Buy Remaining Stake in Dragonbio, Noah Holdings Announces Buyback - Analyst Blog
Swarup Gupta - Zacks Investment Research - Thu Jul 09, 3:36PM CDT
Markets had a dismal week, despite a series of measures taken by the government to boost markets.
NPD: 2.45 (+0.01), SOL: 1.30 (-0.05), NOAH: 24.05 (-1.25), PBR: 6.47 (-0.42), CEO: 120.53 (-3.71), SNP: 70.09 (-2.16), TSL: 7.20 (-0.27), MR: 27.94 (+0.07), PTR: 70.93 (-1.99), ZNH: 29.65 (+0.01), BABA: 75.92 (-1.64)

China Nepstar Chain Drugstore receives going private proposal at USD1.30 per share or USD2.60 per ADS in cash
M2 - Tue Jul 07, 3:38AM CDT
Retail drugstore China Nepstar Chain Drugstore (NYSE:NPD) said on Monday that its board of directors has received a preliminary non-binding proposal letter for the acquisition of all of the outstanding ordinary shares at USD1.30 per share and the American Depositary Shares at USD2.60 per ADS in cash in a going private transaction.
NPD: 2.45 (+0.01)

China Nepstar Chain Drugstore Ltd. Announces Receipt of "Going Private" Proposal
PR Newswire - Mon Jul 06, 2:49AM CDT
China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company" , a leading retail drugstore chain in China based on the number of directly operated stores, today announced that its board of directors has received a preliminary non-binding proposal letter, dated July 6, 2015, from Simin Zhang, chairman of the board of directors of the Company, and China Neptunus Drugstore Holding Ltd., an investment vehicle wholly owned by Mr. Zhang("Neptunus Holding", and collectively with Mr. Zhang, the "Buyer Parties" , pursuant to which the Buyer Parties propose to acquire all of the outstanding ordinary shares (the "Shares" and the American Depositary Shares ("ADSs", each representing two Shares) of the Company, in both cases, that are not already beneficially owned by the Buyer Parties and their affiliates at a price of US$1.30 per Share or US$2.60 per ADS, as the case may be, in cash, in a going private transaction(the "Acquisition" , subject to certain conditions.
NPD: 2.45 (+0.01)

China Nepstar Chain Drugstore Up 9.5%, Shares Break Through Resistance (NPD)
Comtex SmarTrend(R) - Mon Jun 08, 11:47AM CDT
China Nepstar Chain Drugstore (NYSE:NPD) is one of today's best performing low-priced stocks, up 9.5% to $2.77 on 1.3x average daily volume. Thus far today, China Nepstar Chain Drugstore has traded 297,000 shares, vs. average volume of 230,000 shares per day. The stock has outperformed the Dow (9.5% to the Dow's -0.2%) and outperformed the S&P 500 (9.5% to the S&P's -0.3%) during today's trading.
NPD: 2.45 (+0.01)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 48

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 33

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 40

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 56

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 43

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 65

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 41

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading

Top 5 Most Recently Viewed Articles

Emerging Trends in Cannabis Testing Market Boost Growth

Updated Category News Views 468

The Transforming Landscape of the Cannabis Testing Market The cannabis testing market is entering an exciting phase of development, projected to grow significantly in the coming years. The estimated expansion of USD 2.05 billion from 2024 to 2028 reflects an increasing demand intertwined with the rise of medical cannabis. With a compound annual growth rate (CAGR) of...

Continue Reading
CeraVe's Innovative Haircare Campaign with Celebrity Stars

Updated Category News Views 269

CeraVe Unveils Engaging Haircare Campaign CeraVe has recently launched a groundbreaking campaign titled 'Head of CeraVe', focusing on destigmatizing dandruff while raising awareness about effective scalp solutions. This timely initiative shines a light on the new Hydrating Anti-Dandruff and Gentle Hydrating haircare lines. Understanding Dandruff and Its Impact Surveys...

Continue Reading
US Weather Forecasting System Market Expected Growth by 2029

Updated Category News Views 134

Understanding the US Weather Forecasting System Market The US Weather Forecasting System market is on track for significant growth, anticipated to reach USD 832.2 million by 2029. This figure marks a substantial increase from USD 620.1 million in 2024, reflecting a compound annual growth rate (CAGR) of 6.1% during the forecast period. As the demand for precise weather...

Continue Reading
Market Insights: NVIDIA's Earnings and Super Micro's Surge

Updated Category News Views 125

Market Performance Overview As Wednesday's trading unfolded, all three major indices saw a positive uptick, marking a welcome change for investors. The S&P 500 and Nasdaq 100 aimed to break a four-day losing streak, boosted by optimism surrounding tech stocks. NVIDIA Corp.'s Earnings Announcement NVIDIA Corp. (NVDA) has emerged as a central figure within the tech sector,...

Continue Reading
Ups and Downs: New York Community's Earnings Expectations

Updated Category News Views 62

Upcoming Earnings Announcement for New York Community New York Community (NYSE: NYCB) is set to release its quarterly earnings report soon. This announcement has created a buzz within the investment community, as many anticipate valuable insights regarding the company's performance. Analysts' Expectations Analysts predict that New York Community will report an earnings...

Continue Reading